| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 2138425 | Leukemia Research | 2009 | 6 Pages | 
Abstract
												In this study, treatment of lymphoid tumor cells with low dose clofarabine upregulated the expression of Sp17 and SPAN-Xb. This was associated with an increase in hypomethylated CpG dinucleotides and a decrease in global DNA methylation, as demonstrated by decreases in the percent of methylated Alu repeats. The most optimal concentration of clofarabine to induce DNA hypomethylation and CT antigen expression was between 1 × 10−9 and 1 × 10−8 M. Above this, clofarabine resulted in tumor cell growth inhibition and apoptosis. Our results provide the first evidence for the CT antigen-inducing and DNA hypomethylating property of low concentration clofarabine.
Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cancer Research
												
											Authors
												Yana Zhang, Masum Shahriar, Jian Zhang, Sharif Uddin Ahmed, Seah H. Lim, 
											